256 related articles for article (PubMed ID: 17009047)
21. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine.
Meshulam Y; Cohen G; Chapman S; Alkalai D; Levy A
J Appl Toxicol; 2001 Dec; 21 Suppl 1():S75-8. PubMed ID: 11920924
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Karasova J
Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors.
Zaharko DS; Grieshaber CK; Plowman J; Cradock JC
Cancer Treat Rep; 1986 Dec; 70(12):1415-21. PubMed ID: 3791254
[TBL] [Abstract][Full Text] [Related]
25. Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity.
Katalan S; Lazar S; Brandeis R; Rabinovitz I; Egoz I; Grauer E; Bloch-Shilderman E; Raveh L
Arch Toxicol; 2013 Feb; 87(2):347-60. PubMed ID: 23052190
[TBL] [Abstract][Full Text] [Related]
26. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
Singh-Joy SD; McLain VC
Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
[TBL] [Abstract][Full Text] [Related]
27. Relation of preclinical toxicology to findings in early clinical trials.
Grieshaber CK; Marsoni S
Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
[TBL] [Abstract][Full Text] [Related]
28. GB toxicity reassessed using newer techniques for estimation of human toxicity from animal inhalation toxicity data: new method for estimating acute human toxicity (GB).
Bide RW; Armour SJ; Yee E
J Appl Toxicol; 2005; 25(5):393-409. PubMed ID: 16092087
[TBL] [Abstract][Full Text] [Related]
29. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis.
van Helden HP; Trap HC; Kuijpers WC; Oostdijk JP; Benschop HP; Langenberg JP
J Appl Toxicol; 2004; 24(1):59-68. PubMed ID: 14745848
[TBL] [Abstract][Full Text] [Related]
30. Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance.
Mahmood I; Green MD; Fisher JE
J Clin Pharmacol; 2003 Jul; 43(7):692-7. PubMed ID: 12861964
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
Ward KW; Smith BR
Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic prophylaxis against nerve agent poisoning.
Layish I; Krivoy A; Rotman E; Finkelstein A; Tashma Z; Yehezkelli Y
Isr Med Assoc J; 2005 Mar; 7(3):182-7. PubMed ID: 15792266
[TBL] [Abstract][Full Text] [Related]
34. A symptomatological assessment of organophosphate-induced lethality in mice: comparison of atropine and clonidine protection.
Liu WF
Toxicol Lett; 1991 Apr; 56(1-2):19-32. PubMed ID: 2017778
[TBL] [Abstract][Full Text] [Related]
35. Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters.
Ward KW; Coon DJ; Magiera D; Bhadresa S; Nisbett E; Lawrence MS
Drug Metab Dispos; 2008 Apr; 36(4):715-20. PubMed ID: 18227143
[TBL] [Abstract][Full Text] [Related]
36. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
Jonker DM; Voskuyl RA; Danhof M
Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
[TBL] [Abstract][Full Text] [Related]
37. Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs.
Che MM; Conti M; Chanda S; Boylan M; Sabnekar P; Rezk P; Amari E; Sciuto AM; Gordon RK; Doctor BP; Nambiar MP
Toxicol Appl Pharmacol; 2009 Sep; 239(3):251-7. PubMed ID: 19523969
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic aspects of organophosphate poisoning.
Worek F; Koller M; Thiermann H; Szinicz L
Toxicology; 2005 Oct; 214(3):182-9. PubMed ID: 16051411
[TBL] [Abstract][Full Text] [Related]
39. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.
Thiermann H; Szinicz L; Eyer P; Felgenhauer N; Zilker T; Worek F
Toxicology; 2007 Apr; 233(1-3):145-54. PubMed ID: 17161895
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
